Does autoimmunity play a role in the pathophysiology of premature ovarian ageing? 2008

Andrea Weghofer, and Hayama Brill, and Ramona Feichtinger, and David Barad, and Norbert Gleicher
Department of Obstetrics and Gynecology, Medical University Vienna, Austria. andrea.weghofer@meduniwien.ac.at

To determine a possible causative association between autoimmunity and premature ovarian ageing (POA), 394 women undergoing IVF at an academically affiliated private IVF centre were retrospectively evaluated for the presence of autoimmune-related diseases. Out of 162 POA women, 13 (8.0%) demonstrated a history of autoimmune disease(s), while autoimmunity was present in 28 (12.1%) of 232 controls. POA women with poor response (four oocytes or fewer) despite high-dose treatment presented autoimmunity in 7.9%, compared with 12.1% control subjects without autoimmune diseases. When family history was considered (patient and/or first-degree relatives), at least one autoimmune disease was reported in 14 (8.6%) POA and 31 (13.4%) controls with comparable distributions of autoimmune diseases among both groups. Infertile women with premature ovarian ageing and age-appropriate ovarian function show high but comparable prevalences of autoimmune-related diseases. These findings support the assumption that aetiologies other than autoimmune disease lead to POA.

UI MeSH Term Description Entries
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D015897 Comorbidity The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences
D016649 Primary Ovarian Insufficiency Cessation of ovarian function after MENARCHE but before the age of 40, without or with OVARIAN FOLLICLE depletion. It is characterized by the presence of OLIGOMENORRHEA or AMENORRHEA, elevated GONADOTROPINS, and low ESTRADIOL levels. It is a state of female HYPERGONADOTROPIC HYPOGONADISM. Etiologies include genetic defects, autoimmune processes, chemotherapy, radiation, and infections. The most commonly known genetic cause is the expansion of a CGG repeat to 55 to 199 copies in the 5' untranslated region in the X-linked FMR1 gene. Gonadotropin-Resistant Ovary Syndrome,Ovarian Failure, Premature,Resistant Ovary Syndrome,FMR1-Related Primary Ovarian Insufficiency,Fragile X Premature Ovarian Failure,Fragile X-Associated Primary Ovarian Insufficiency,Hypergonadotropic Ovarian Failure, X-Linked,Premature Ovarian Failure,Premature Ovarian Failure 1,Premature Ovarian Failure, X-Linked,Primary Ovarian Insufficiency, Fragile X-Associated,X-Linked Hypergonadotropic Ovarian Failure,FMR1 Related Primary Ovarian Insufficiency,Fragile X Associated Primary Ovarian Insufficiency,Gonadotropin Resistant Ovary Syndrome,Hypergonadotropic Ovarian Failure, X Linked,Ovarian Insufficiency, Primary,Premature Ovarian Failure, X Linked,Primary Ovarian Insufficiency, Fragile X Associated,X Linked Hypergonadotropic Ovarian Failure

Related Publications

Andrea Weghofer, and Hayama Brill, and Ramona Feichtinger, and David Barad, and Norbert Gleicher
January 2010, Journal of mid-life health,
Andrea Weghofer, and Hayama Brill, and Ramona Feichtinger, and David Barad, and Norbert Gleicher
January 2011, Advances in experimental medicine and biology,
Andrea Weghofer, and Hayama Brill, and Ramona Feichtinger, and David Barad, and Norbert Gleicher
August 2015, Iranian journal of reproductive medicine,
Andrea Weghofer, and Hayama Brill, and Ramona Feichtinger, and David Barad, and Norbert Gleicher
February 2021, Nigerian journal of clinical practice,
Andrea Weghofer, and Hayama Brill, and Ramona Feichtinger, and David Barad, and Norbert Gleicher
February 2018, Neuro endocrinology letters,
Andrea Weghofer, and Hayama Brill, and Ramona Feichtinger, and David Barad, and Norbert Gleicher
August 2019, Macromolecules,
Andrea Weghofer, and Hayama Brill, and Ramona Feichtinger, and David Barad, and Norbert Gleicher
July 2019, Archives of medical science : AMS,
Andrea Weghofer, and Hayama Brill, and Ramona Feichtinger, and David Barad, and Norbert Gleicher
January 1991, International journal of fertility,
Andrea Weghofer, and Hayama Brill, and Ramona Feichtinger, and David Barad, and Norbert Gleicher
January 2014, International journal of fertility & sterility,
Andrea Weghofer, and Hayama Brill, and Ramona Feichtinger, and David Barad, and Norbert Gleicher
February 1997, Endocrine reviews,
Copied contents to your clipboard!